510(k) K230884

AVVIGO'+ Multi-Modality Guidance System by Boston Scientific Corporation — Product Code DQK

K230884 is an FDA 510(k) premarket notification submitted by Boston Scientific Corporation for the device "AVVIGO'+ Multi-Modality Guidance System". The FDA issued a decision of Substantially Equivalent on September 26, 2023. The device falls under product code DQK (Computer, Diagnostic, Programmable), a Class II device regulated under 21 CFR 870.1425. Boston Scientific Corporation has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 26, 2023
Date Received
March 30, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Computer, Diagnostic, Programmable
Device Class
Class II
Regulation Number
870.1425
Review Panel
CV
Submission Type